Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-23 Purchase | 2026-06-24 4:11 pm | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO | 2,400 | $4.5617 | $10,948 | 3,210,179 (Indirect Direct) | View |
| 2026-06-15 Purchase | 2026-06-16 4:15 pm | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 6,035 | $4.15 | $25,045 | 382,531 (Direct) | View |
| 2026-01-16 Purchase | 2026-01-21 09:09 am | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 5,250 | $4.76 | $24,990 | 11,050 (Direct) | View |
| 2026-01-15 Purchase | 2026-01-20 09:17 am | Immuneering Corp | IMRX | Schall Thomas J. Director | 21,645 | $4.6681 | $101,041 | 74,530 (Direct) | View |
| 2026-01-15 Purchase | 2026-01-16 4:07 pm | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 2,298 | $4.57 | $10,502 | 376,496 (Direct) | View |
| 2026-01-13 Purchase | 2026-01-15 08:06 am | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 2,626 | $4.153 | $10,906 | 25,970 (Direct) | View |
| 2026-01-12 Purchase | 2026-01-14 08:10 am | Immuneering Corp | IMRX | Feinberg Peter Director | 20,000 | $4.3452 | $86,904 | 1,161,064 (Indirect Direct) | View |
| 2025-10-03 Purchase | 2025-10-07 08:56 am | Immuneering Corp | IMRX | Feinberg Peter Director | 7,500 | $6.67 | $50,025 | 1,141,064 (Indirect Direct) | View |
| 2025-10-01 Purchase | 2025-10-02 09:02 am | Immuneering Corp | IMRX | Morales Mallory Chief Accounting Officer | 300 | $6.39 | $1,917 | 27,533 (Direct) | View |
| 2025-10-01 Purchase | 2025-10-02 08:57 am | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 800 | $6.3792 | $5,103 | 23,344 (Direct) | View |
| 2025-10-01 Purchase | 2025-10-02 08:52 am | Immuneering Corp | IMRX | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | 1,020 | $6.8299 | $6,966 | 4,870 (Direct) | View |
| 2025-09-30 Purchase | 2025-10-01 08:59 am | Immuneering Corp | IMRX | Feinberg Peter Director | 7,500 | $7.0307 | $52,730 | 1,133,564 (Indirect Direct) | View |
| 2025-09-29 Purchase | 2025-09-30 09:00 am | Immuneering Corp | IMRX | Feinberg Peter Director | 5,000 | $7.18 | $35,900 | 1,126,064 (Indirect Direct) | View |
| 2025-07-02 Purchase | 2025-07-07 08:59 am | Immuneering Corp | IMRX | HAUSMAN DIANA Director | 5,500 | $3.6114 | $19,863 | 5,500 (Indirect Direct) | View |
| 2025-07-02 Purchase | 2025-07-07 08:52 am | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 700 | $3.5695 | $2,499 | 10,729 (Direct) | View |
| 2025-07-01 Purchase | 2025-07-03 09:12 am | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO 10% Owner | 10,000 | $3.4879 | $34,879 | 3,207,779 (Indirect Direct) | View |
| 2025-06-27 Purchase | 2025-06-30 09:09 am | Immuneering Corp | IMRX | Schall Thomas J. Director | 9,500 | $3.6619 | $34,788 | 52,885 (Direct) | View |
| 2025-06-20 Purchase | 2025-06-24 09:01 am | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 13,422 | $2.5791 | $34,616 | 359,318 (Direct) | View |
| 2025-06-20 Purchase | 2025-06-24 08:52 am | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 1,900 | $2.5285 | $4,804 | 5,800 (Direct) | View |
| 2025-06-18 Purchase | 2025-06-23 09:09 am | Immuneering Corp | IMRX | Feinberg Peter Director | 25,000 | $2.5275 | $63,188 | 1,121,064 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-16 Option Award | 2026-07-17 4:29 pm | N/A 2036-07-16 | Immuneering Corp | IMRX | Gengos Andrew Chief Financial Officer | 650,000 | $0 | 650,000 (Direct) | View |
Ownership | 2026-07-16 4:10 pm | N/A N/A | Immuneering Corp | IMRX | Gengos Andrew Chief Financial Officer | 0 | $0 | 225,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-11 5:37 pm | N/A 2036-06-11 | Immuneering Corp | IMRX | Schall Thomas J. Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-11 5:33 pm | N/A 2036-06-11 | Immuneering Corp | IMRX | HAUSMAN DIANA Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-11 5:29 pm | N/A 2036-06-11 | Immuneering Corp | IMRX | CARPENTER ROBERT J Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-11 5:26 pm | N/A 2036-06-11 | Immuneering Corp | IMRX | KEATING LAURIE Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-11 5:23 pm | N/A 2036-06-11 | Immuneering Corp | IMRX | Feinberg Peter Director | 33,350 | $0 | 33,350 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-17 4:46 pm | N/A N/A | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 3,628 | $4.2925 | 29,598 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:44 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | 176,000 | $0 | 176,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:37 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Brakewood Harold Eugene Chief Business Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:32 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 344,000 | $0 | 344,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:27 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Matushansky Igor Chief Medical Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:22 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Morales Mallory SVP Finance, CAO | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:14 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 140,000 | $0 | 140,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-05 08:10 am | N/A 2036-02-03 | Immuneering Corp | IMRX | Zeskind Benjamin J. PRESIDENT AND CEO | 688,000 | $0 | 688,000 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-02 4:56 pm | N/A 2036-01-01 | Immuneering Corp | IMRX | KEATING LAURIE Director | 7,888 | $0 | 7,888 (Direct) | View |
| 2026-01-01 Option Award | 2026-01-02 4:50 pm | N/A 2036-01-01 | Immuneering Corp | IMRX | Feinberg Peter Director | 7,888 | $0 | 7,888 (Direct) | View |
| 2025-09-15 Option Award | 2025-09-17 4:41 pm | N/A N/A | Immuneering Corp | IMRX | Neufeld Leah R CHIEF PEOPLE OFFICER | 11,815 | $1.428 | 22,544 (Direct) | View |
| 2025-09-15 Option Award | 2025-09-17 4:35 pm | N/A N/A | Immuneering Corp | IMRX | Morales Mallory Chief Accounting Officer | 14,497 | $1.428 | 27,233 (Direct) | View |
| 2025-09-15 Option Award | 2025-09-17 4:30 pm | N/A N/A | Immuneering Corp | IMRX | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | 14,880 | $1.428 | 374,198 (Direct) | View |